HKSE - Delayed Quote HKD

Yonghe Medical Group Co., Ltd. (2279.HK)

1.050
+0.090
+(9.37%)
At close: May 9 at 3:59:25 PM GMT+8
Loading Chart for 2279.HK
  • Previous Close 0.960
  • Open 0.980
  • Bid 1.050 x --
  • Ask 1.050 x --
  • Day's Range 0.960 - 1.070
  • 52 Week Range 0.600 - 1.900
  • Volume 566,000
  • Avg. Volume 261,867
  • Market Cap (intraday) 525.166M
  • Beta (5Y Monthly) 0.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.480
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 30, 2022
  • 1y Target Est 1.60

Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; and wig business. The company was founded in 2005 and is headquartered in Beijing, China.

www.yonghegroup.cn

3,514

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2279.HK

View More

Performance Overview: 2279.HK

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2279.HK
16.67%
HANG SENG INDEX (^HSI)
14.00%

1-Year Return

2279.HK
10.26%
HANG SENG INDEX (^HSI)
23.36%

3-Year Return

2279.HK
88.95%
HANG SENG INDEX (^HSI)
14.33%

5-Year Return

2279.HK
93.34%
HANG SENG INDEX (^HSI)
5.62%

Compare To: 2279.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2279.HK

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    480.15M

  • Enterprise Value

    672.71M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.25

  • Price/Book (mrq)

    0.63

  • Enterprise Value/Revenue

    0.35

  • Enterprise Value/EBITDA

    6.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -12.54%

  • Return on Assets (ttm)

    -3.66%

  • Return on Equity (ttm)

    -27.36%

  • Revenue (ttm)

    1.8B

  • Net Income Avi to Common (ttm)

    -226.34M

  • Diluted EPS (ttm)

    -0.480

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    540.84M

  • Total Debt/Equity (mrq)

    93.46%

  • Levered Free Cash Flow (ttm)

    151.87M

Research Analysis: 2279.HK

View More

Company Insights: 2279.HK

Research Reports: 2279.HK

View More

People Also Watch